FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4301585701> ?p ?o ?g. }

• W4301585701 abstract "The function of white adipose tissue as an energy reservoir is impaired in obesity, leading to lipid spillover and ectopic lipid deposition. Adipose tissue inflammation can reduce the efficacy of lipid storage in adipocytes by augmenting basal lipolysis through producing interleukin-6 (IL-6). Therefore, pharmacological compounds targeting adipose tissue inflammation or IL-6 signaling might have the potential to combat obesity. This study aims to investigate the impact of Phillyrin, which is frequently used for treating respiratory infections in clinics in China, on obesity-related metabolic dysfunctions. Firstly, a mouse model of diet-induced obesity is used to assess the pharmacological applications of Phillyrin on obesity in vivo. Secondly, ex vivo culture of adipose tissue explants is utilized to investigate actions of Phillyrin on IL-6-linked basal lipolysis. Thirdly, a mouse model of IL-6 injection into visceral adipose tissue is explored to confirm the anti-basal lipolytic effect of Phillyrin against IL-6 in vivo. The results show that Phillyrin treatment reduces circulating level of glycerol, decreases hepatic steatosis and improves insulin sensitivity in obese mice. Meanwhile, Phillyrin attenuates obesity-related inflammation and IL-6 production in adipose tissue in obese mice. Furthermore, Phillyrin treatment results in resistance to IL-6-induced basal lipolysis in adipose tissue through suppressing expression of adipose triglyceride lipase (ATGL) both in vivo and in vitro. Collectively, these findings suggest that Phillyrin can restrain lipid efflux from inflamed adipose tissue in obesity by inhibiting IL-6-initiated basal lipolysis and ATGL expression, and thus is a potential candidate in the treatment of obesity-associated complications." @default.
• W4301585701 created "2022-10-05" @default.
• W4301585701 creator A5015633173 @default.
• W4301585701 creator A5032114421 @default.
• W4301585701 creator A5034338177 @default.
• W4301585701 creator A5061391281 @default.
• W4301585701 creator A5077619931 @default.
• W4301585701 creator A5081831381 @default.
• W4301585701 creator A5087059542 @default.
• W4301585701 date "2022-10-05" @default.
• W4301585701 modified "2023-10-09" @default.
• W4301585701 title "Phillyrin restores metabolic disorders in mice fed with high-fat diet through inhibition of interleukin-6-mediated basal lipolysis" @default.
• W4301585701 cites W1973740991 @default.
• W4301585701 cites W1980783399 @default.
• W4301585701 cites W1995092745 @default.
• W4301585701 cites W2031533316 @default.
• W4301585701 cites W2035833905 @default.
• W4301585701 cites W2038281128 @default.
• W4301585701 cites W2061412618 @default.
• W4301585701 cites W2074742267 @default.
• W4301585701 cites W2077991483 @default.
• W4301585701 cites W2082974347 @default.
• W4301585701 cites W2110839026 @default.
• W4301585701 cites W2117755174 @default.
• W4301585701 cites W2141085894 @default.
• W4301585701 cites W2160078193 @default.
• W4301585701 cites W2179438025 @default.
• W4301585701 cites W2201783325 @default.
• W4301585701 cites W2415267894 @default.
• W4301585701 cites W2595622083 @default.
• W4301585701 cites W2601642277 @default.
• W4301585701 cites W2799321585 @default.
• W4301585701 cites W2807696312 @default.
• W4301585701 cites W2872661560 @default.
• W4301585701 cites W2891588795 @default.
• W4301585701 cites W2906928401 @default.
• W4301585701 cites W2911229126 @default.
• W4301585701 cites W2954082649 @default.
• W4301585701 cites W2967265235 @default.
• W4301585701 cites W2980604510 @default.
• W4301585701 cites W2994916363 @default.
• W4301585701 cites W3000553525 @default.
• W4301585701 cites W3002801990 @default.
• W4301585701 cites W3023759921 @default.
• W4301585701 cites W3137727036 @default.
• W4301585701 cites W3153396515 @default.
• W4301585701 cites W3159232901 @default.
• W4301585701 cites W3197182690 @default.
• W4301585701 cites W4280547630 @default.
• W4301585701 cites W4282549827 @default.
• W4301585701 doi "https://doi.org/10.3389/fnut.2022.956218" @default.
• W4301585701 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36276810" @default.
• W4301585701 hasPublicationYear "2022" @default.
• W4301585701 type Work @default.
• W4301585701 citedByCount "2" @default.
• W4301585701 countsByYear W43015857012023 @default.
• W4301585701 crossrefType "journal-article" @default.
• W4301585701 hasAuthorship W4301585701A5015633173 @default.
• W4301585701 hasAuthorship W4301585701A5032114421 @default.
• W4301585701 hasAuthorship W4301585701A5034338177 @default.
• W4301585701 hasAuthorship W4301585701A5061391281 @default.
• W4301585701 hasAuthorship W4301585701A5077619931 @default.
• W4301585701 hasAuthorship W4301585701A5081831381 @default.
• W4301585701 hasAuthorship W4301585701A5087059542 @default.
• W4301585701 hasBestOaLocation W43015857011 @default.
• W4301585701 hasConcept C126322002 @default.
• W4301585701 hasConcept C134018914 @default.
• W4301585701 hasConcept C140985366 @default.
• W4301585701 hasConcept C150903083 @default.
• W4301585701 hasConcept C151955695 @default.
• W4301585701 hasConcept C171089720 @default.
• W4301585701 hasConcept C17675752 @default.
• W4301585701 hasConcept C194832188 @default.
• W4301585701 hasConcept C207001950 @default.
• W4301585701 hasConcept C26291073 @default.
• W4301585701 hasConcept C2776175330 @default.
• W4301585701 hasConcept C2776914184 @default.
• W4301585701 hasConcept C2777062983 @default.
• W4301585701 hasConcept C2777391703 @default.
• W4301585701 hasConcept C2778163477 @default.
• W4301585701 hasConcept C2778913445 @default.
• W4301585701 hasConcept C39567582 @default.
• W4301585701 hasConcept C511355011 @default.
• W4301585701 hasConcept C71924100 @default.
• W4301585701 hasConcept C86803240 @default.
• W4301585701 hasConceptScore W4301585701C126322002 @default.
• W4301585701 hasConceptScore W4301585701C134018914 @default.
• W4301585701 hasConceptScore W4301585701C140985366 @default.
• W4301585701 hasConceptScore W4301585701C150903083 @default.
• W4301585701 hasConceptScore W4301585701C151955695 @default.
• W4301585701 hasConceptScore W4301585701C171089720 @default.
• W4301585701 hasConceptScore W4301585701C17675752 @default.
• W4301585701 hasConceptScore W4301585701C194832188 @default.
• W4301585701 hasConceptScore W4301585701C207001950 @default.
• W4301585701 hasConceptScore W4301585701C26291073 @default.
• W4301585701 hasConceptScore W4301585701C2776175330 @default.
• W4301585701 hasConceptScore W4301585701C2776914184 @default.
• W4301585701 hasConceptScore W4301585701C2777062983 @default.
• W4301585701 hasConceptScore W4301585701C2777391703 @default.
• W4301585701 hasConceptScore W4301585701C2778163477 @default.

• next